ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Ajay Dhankhar Joins Lazard as a Managing Director in Healthcare Group, Financial Advisory

Lazard Ltd (NYSE: LAZ) announced today that Ajay Dhankhar has joined the firm as a Managing Director in the Healthcare Group within Financial Advisory, effective immediately. Based in New York, Mr. Dhankhar will serve as Global Head of Medical Technology, Diagnostics and Tools. He will also advise clients in other healthcare segments, including biopharmaceuticals, and healthcare information and technology.

“Ajay brings deep experience to our Healthcare practice as a trusted strategic advisor to C-suite executives and boards,” said David Gluckman, Global Head of the Healthcare Group at Lazard. “The healthcare sector, including medical devices and technology, is experiencing strong growth that is set to continue in the years ahead. Adding a seasoned healthcare advisor like Ajay will ensure Lazard continues to provide clients with the very best possible advice.”

Mr. Dhankhar is a former biochemist and a highly experienced healthcare advisor, with particular expertise in the fields of medical technology, diagnostics and tools, and biopharmaceuticals. He is an established thought leader, espousing the concept that portfolio optimization through M&A, joint ventures and divestments, when coupled with rational capital allocation, can help companies deliver sector- and industry-leading shareholder value.

Mr. Dhankhar has advised on more than 50 major transactions, including four of the 10 largest mergers and/or restructurings to have taken place in the life sciences industry in recent years. He joins Lazard from McKinsey & Company, where he was a Senior Partner and Global Leader of the firm’s Life Sciences Strategy, M&A, Corporate Finance and Enterprise Risk practices. He previously served as Global Leader of McKinsey’s Life Sciences R&D practice.

Mr. Dhankhar has a bachelor’s degree in Physics and Computer Science from Angelo State University and both a master’s degree and a doctorate in Molecular Biophysics and Biochemistry from Yale University.

About Lazard

Lazard, one of the world's preeminent financial advisory and asset management firms, operates from 40 cities across 25 countries in North and South America, Europe, Asia and Australia. With origins dating to 1848, the firm provides advice on mergers and acquisitions, strategic matters, restructuring and capital structure, capital raising and corporate finance, as well as asset management services to corporations, partnerships, institutions, governments and individuals. For more information on Lazard, please visit www.lazard.com. Follow Lazard at @Lazard

LAZ_FAPE 

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  230.30
+1.05 (0.46%)
AAPL  269.70
+0.70 (0.26%)
AMD  264.33
+6.32 (2.45%)
BAC  52.58
-0.29 (-0.55%)
GOOG  275.17
+6.74 (2.51%)
META  751.67
+0.23 (0.03%)
MSFT  541.55
-0.52 (-0.10%)
NVDA  207.04
+6.01 (2.99%)
ORCL  275.30
-5.53 (-1.97%)
TSLA  461.51
+0.96 (0.21%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.